中国药物经济学2024，Vol.19Issue(1)：20-26,7.DOI:10.12010/j.issn.1673-5846.2024.01.003
某院3121例银屑病住院患者用药及经济负担
Drug Use and Economic Burden of 3 121 Inpatients with Psoriasis in A Hospital
摘要
Abstract
Objective To analyze the drug use and economic burden of inpatients with psoriasis and to provide a basis for rational use of medicines and optimal allocation of health resources.Methods The inpatient medical record system of the Second Xiangya Hospital of Central South University was selected from the whole group,and the information of inpatients with psoriasis from 2012 to 2022 was collected and analyzed for medication use and economic burden.Results A total of 3 121 patients were included,most of which were males,patients aged 30～60 years,people from Hunan Province.Glucocorticoids,antihistamines and vitamin D3 analogues were the most commonly used drugs,and monoantibody biological agents was the most expensive drug.The total hospitalization cost per capita was(10 216.97±7 303.53)yuan,and the average western medicine cost per capita was(5 998.60±5 913.94)yuan.The main influencing factors of total hospitalization cost of psoriasis inpatients were western medicine cost,length of stay,whether there were complications,clinical classification of psoriasis and whether biological agents were used in turn.Conclusion The costs of psoriasis inpatients were mainly spent on drugs,so through reasonable and personalized drug program and other measures can reduce the economic burden of patients with psoriasis to a certain extent.关键词
银屑病/合理用药/经济负担Key words
Psoriasis/Rational use of medicines/Economic burden分类
医药卫生引用本文复制引用
万小敏,刘金艳,刘俏,易利丹,罗霞..某院3121例银屑病住院患者用药及经济负担[J].中国药物经济学,2024,19(1):20-26,7.基金项目
湖南省自然科学基金(2021JJ40817、2022JJ80040、2023JJ60503) （2021JJ40817、2022JJ80040、2023JJ60503）
湖南省卫健委科研项目(202113050611、202113050283、202213053462) （202113050611、202113050283、202213053462）
